- Report
- January 2026
- 150 Pages
Global
From €5332EUR$5,950USD£4,649GBP
- Report
- January 2026
- 189 Pages
Global
From €3177EUR$3,545USD£2,770GBP
€3530EUR$3,939USD£3,077GBP
- Report
- January 2026
- 186 Pages
Global
From €3177EUR$3,545USD£2,770GBP
€3530EUR$3,939USD£3,077GBP
- Report
- January 2026
- 188 Pages
Global
From €3177EUR$3,545USD£2,770GBP
€3530EUR$3,939USD£3,077GBP
- Report
- January 2026
- 180 Pages
Global
From €3177EUR$3,545USD£2,770GBP
€3530EUR$3,939USD£3,077GBP
- Report
- August 2025
- 188 Pages
Global
From €3177EUR$3,545USD£2,770GBP
€3530EUR$3,939USD£3,077GBP
- Report
- August 2025
- 184 Pages
Global
From €3177EUR$3,545USD£2,770GBP
€3530EUR$3,939USD£3,077GBP
- Report
- August 2025
- 194 Pages
Global
From €3177EUR$3,545USD£2,770GBP
€3530EUR$3,939USD£3,077GBP
- Report
- August 2025
- 198 Pages
Global
From €3177EUR$3,545USD£2,770GBP
€3530EUR$3,939USD£3,077GBP
- Report
- January 2026
- 180 Pages
Global
From €4033EUR$4,500USD£3,516GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,508GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,508GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,508GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,508GBP
- Report
- January 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,508GBP
- Report
- April 2026
- 487 Pages
Global
From €5243EUR$5,850USD£4,570GBP
- Report
- April 2026
- 168 Pages
Global
From €5243EUR$5,850USD£4,570GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,508GBP
- Report
- July 2025
- 350 Pages
Global
From €4435EUR$4,949USD£3,867GBP
- Report
- May 2024
- 200 Pages
Global
From €3719EUR$4,150USD£3,242GBP

Iodine-123 is a radioactive isotope of iodine used in Nuclear Medicine and Radiopharmacology. It is used in a variety of medical imaging procedures, such as thyroid scans, to diagnose and treat thyroid diseases. It is also used in the diagnosis of certain types of cancer, such as neuroendocrine tumors. Iodine-123 has a short half-life of 13.2 hours, making it ideal for use in Nuclear Medicine. It is produced in nuclear reactors and cyclotrons, and is available in a variety of formulations, including capsules, solutions, and injectables.
Companies in the Iodine-123 market include GE Healthcare, Mallinckrodt Pharmaceuticals, Jubilant DraxImage, and Bracco Diagnostics. Show Less Read more